According to reports, the Union Cabinet decided to not discuss the National Pharmaceutical Pricing Policy (NPPP) in a recent meeting due to concerns over the NPPP’s price-fixing mechanism policy. The finance ministry raised concerns over the NPPP, and, as a result, the delay in discussion threatens to prevent the NPPP from being finalized and submitted to the Supreme Court by its given deadline of November 25. A group of ministers had originally suggested the price-fixing mechanism, though the finance ministry has found loopholes in its legislature.
Featured News
Florida Sues Prime Therapeutics, Express Scripts Over Alleged Price Fixing
Aug 27, 2026 by
CPI
Iowa, Montana Ask Supreme Court to Halt Paramount Merger Challenge
Aug 27, 2026 by
CPI
Google Reaches £260 Million Deal to Settle UK App Developer Case
Aug 27, 2026 by
CPI
KKR Agrees to Record $250 Million Penalty in US Merger-Filing Case
Aug 27, 2026 by
CPI
Poland Seeks €250 Million EU Fine Against Meta Over Scam Ads
Aug 27, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – State Attorneys General
Aug 27, 2026 by
CPI
CPI Talks… with Jonathan Skrmetti, Attorney General of Tennessee
Aug 27, 2026 by
Jonathan Skrmetti
What the Live Nation Jury Instructions Tell Us About California’s Unfair Competition Law
Aug 27, 2026 by
Henry Hauser, Brent Nakamura, Ashley Kaplan, Brian Wang & Cari Jeffries
From Backroom Deals to Public Scrutiny: The Tunney Act’s Past, Present, and Future
Aug 27, 2026 by
Christina M. Black & Ashley A. Locke
Understanding the Fragility of Economic Concentration Through the Principles of Ecology
Aug 27, 2026 by
Alexandra Spring